Developing new methods to create complex molecules for medicine
Harnessing Alkyl Amines and Alkyl Alcohols in Cross-Coupling Reactions
This study is working on new ways to create complex molecules that could help develop better medicines, which means patients might eventually benefit from new treatments made using these innovative methods.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Delaware NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11077249 on NIH RePORTER |
What this research studies
This research focuses on creating new methods to synthesize complex molecules that can lead to the development of new medicines. By utilizing alkyl alcohols and amines, the researchers aim to efficiently construct bonds to saturated carbon atoms, which are crucial for the three-dimensional shape of bioactive compounds. The project will explore innovative cross-coupling reactions that can produce highly pure and diverse molecular structures, potentially leading to breakthroughs in drug development. Patients may benefit from new treatments derived from these advanced synthetic methods.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals with conditions that could be treated by new medications developed from these synthetic methods.
Not a fit: Patients who are not seeking new treatment options or who do not have conditions related to the diseases targeted by the new medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective medications for various diseases.
How similar studies have performed: Other research has shown success in developing new synthetic methods for drug discovery, indicating that this approach has potential for significant advancements.
Where this research is happening
Newark, UNITED STATES
- University of Delaware — Newark, United States (Active)
Researchers
- Principal investigator: Watson, Mary P — University of Delaware
- Study coordinator: Watson, Mary P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.